US Stock MarketDetailed Quotes

ZBIO Zenas BioPharma

Watchlist
  • 7.015
  • +0.010+0.14%
Close Feb 25 16:00 ET
  • 7.015
  • 0.0000.00%
Post 20:01 ET
293.16MMarket Cap-2.27P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

Comments

    $Zenas BioPharma (ZBIO.US)$
    Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases
    Wednesday, 5th February at 7:05 am
    - Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function-
    -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in third quarter 2025-
    -Topline results from pivotal Phase 3 Tr...
Read more

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More